ADVFN US – Market Content Editor
-
U.S. Inflation Matches Forecasts in February
Consumer prices in the United States increased in February at a pace consistent with economists’ expectations, according to new data published Wednesday by the Labor Department. The report showed that the consumer price index (CPI) rose 0.3% during the month, following a 0.2% increase recorded in January. The monthly gain was in line with market…
-
Gold Holds Steady as Markets Assess Iran Developments and Await U.S. Inflation Data
Spot gold traded largely flat during European hours on Wednesday as investors weighed conflicting signals surrounding the U.S.-Israel conflict with Iran, while keeping a close eye on energy market disruptions and the possibility of a de-escalation in hostilities. Market participants are also awaiting February consumer inflation figures from the United States, which could offer fresh…
-
Oil Price Rebound Could Put Pressure on Wall Street: Dow Jones, S&P, Nasdaq, Futures
U.S. stock index futures pointed to a slightly lower opening on Wednesday, suggesting equities may retreat after ending the previous session with mixed and largely directionless trading. A renewed rise in crude oil prices could weigh on investor sentiment. Oil for April delivery surged nearly 4% after plunging close to 12% during Tuesday’s trading session.…
-
Auddia’s LT350 Unit Signs Preliminary Deal with NYSE Medical REIT for AI Datacenter Pilot
Auddia Inc. (NASDAQ:AUUD) said its LT350 division has entered into a non-binding letter of intent with a medical real estate investment trust listed on the New York Stock Exchange to explore a pilot deployment of solar-powered AI micro–datacenter infrastructure. The proposed project would involve installing LT350’s first solar-integrated AI datacenter canopy at a hospital property…
-
Stellantis Raises €5 Billion in Hybrid Bonds to Strengthen Finances After EV Strategy Reset
Stellantis N.V. (NYSE:STLA) announced it has priced a multi-tranche hybrid bond offering worth €5 billion (about $5.8 billion), accessing capital markets shortly after booking major charges tied to changes in its electric vehicle strategy. The bond sale follows the company’s recent announcement that it would record €22.2 billion in impairments after scaling back its electric…
-
Oracle Shares Jump After Earnings Beat and Higher Revenue Outlook
Oracle Corporation (NYSE:ORCL) reported quarterly results on Tuesday that exceeded analysts’ expectations for both revenue and profit, driven by continued strong expansion in its cloud computing business. The company also lifted its fiscal 2027 revenue forecast, pushing its shares roughly 10% higher in premarket trading on Wednesday. The Austin, Texas-based technology group has increasingly focused…
-
Oil prices swing as markets assess possible IEA reserve release and ongoing supply risks
Oil prices moved higher on Wednesday as traders questioned whether a reported plan by the International Energy Agency to release record levels of emergency reserves would be enough to counter potential supply disruptions linked to the U.S.-Israeli conflict with Iran. Brent crude futures rose 59 cents, or 0.7%, to $88.39 per barrel by 07:27 GMT.…
-
Markets Watch Oil Volatility, Middle East Conflict and CPI Data; Oracle Lifts Outlook: Dow Jones, S&P, Nasdaq, Wall Street Futures
U.S. equity futures traded slightly below the flatline on Wednesday as investors monitored the uncertain trajectory of the conflict in the Middle East. Oil prices swung following reports that the International Energy Agency could release a record volume of emergency reserves, while markets also awaited key U.S. inflation data later in the day. Meanwhile, Oracle…
-
U.S. Stocks Finish Choppy Trading Day Little Changed
After recovering from an early sell-off to end Monday’s session mostly higher, stocks showed a lack of direction over the course of the trading day on Tuesday. The major averages spent the day bouncing back and forth across the unchanged line. The major averages eventually ended the day narrowly mixed. While the Nasdaq inched up…
-
Aptevo Shares Drop Despite Encouraging AML Trial Results
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares plunged about 18% on Tuesday even after the company reported promising interim clinical results for its acute myeloid leukemia (AML) treatment candidate, mipletamig. The clinical-stage biotech said mipletamig, when combined with venetoclax and azacitidine, achieved an 86% clinical benefit rate in newly diagnosed AML patients who are elderly or considered…